Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Fluconazole vs Voriconazole for IFI Prevention in Allo-BMT
NCT00075803Phase 3Completed
- Sponsor
- Medical College of Wisconsin
- Start
- Nov 2003
- Primary completion
- Sep 2006
- Modality
- Orthosteric Ligands
- Countries
- 1
01
Overview
A Phase 3 trial of voriconazole in invasive fungal infection (IFI), sponsored by Medical College of Wisconsin. Started Nov 2003; status: completed.
02
Drugs
voriconazole
03
Conditions
invasive fungal infection (IFI)
Beyond the preview
Go deeper on NCT00075803.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00075803.